Author

Bharati Matta

Feinstein Institute for Medical ResearchORCID 0000-0002-1439-3015Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Betsy Jo BarnesiD· 2 shared Ailing LuiD· 1 shared Amanda HuangiD· 1 shared Benjamin D. HarrisiD· 1 shared Carter C. Somerville· 1 shared Gurinder S. AtwaliD· 1 shared Jason A. CarteriD· 1 shared Jenna BattagliaiD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Betsy Jo BarnesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintAug 26, 2024

IRF5 mediates adaptive immunity via altered glutamine metabolism, mTORC1 signaling and post-transcriptional regulation following T cell receptor activation

Zarina Brune, Ailing Lu, Matthew A. Moss…·Betsy Jo Barnes

This study identifies IRF5 as a key regulator of T cell effector function through mTORC1 signaling, glutamine metabolism, and post-transcriptional control following TCR activation.

1 citation

mousebulk RNA-seq

𝕏 PostBluesky

BioinformaticsbioRxivPreprintMay 9, 2023

Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a- and Siglece-based vaccination induces anti-tumor immunity and inhibits metastasis

Jason A. Carter, Bharati Matta, Jenna Battaglia…·Betsy Jo Barnes

The paper identifies pan-cancer/testis genes and validates their use as therapeutic targets in triple-negative breast cancer through vaccination with Lin28a and Siglece antigens, showing reduced tumor growth and metastasis.

2 citations

mousebulk RNA-seq

𝕏 PostBluesky